Skip To The Main Content
NIH STROKENET: PRIMARY AND SECONDARY PREVENTION TRIALS
Primary and Secondary prevention of stroke is a primary public health concern as approximately 795,000 people in the United States experience a new or recurrent stroke. Efforts in controlling risk factor such as hypertension, diabetes mellitus control, dyslipidemia treatment and smoking cessations programs have had an impact on stroke mortality over the last decade. However stroke remains a leading cause of serious long-term disability in the United States.

PRIMARY AND SECONDARY PREVENTION TRIALS

  • CREST-2: CAROTID REVASCULARIZATION AND MEDICAL MANAGEMENT FOR ASYMPTOMATIC CAROTID STENOSIS TRIAL

  • ARCADIA: ATRIAL CARDIOPATHY AND ANTITHROMBOTIC DRUGS IN PREVENTION AFTER CRYPTOGENIC STROKE